These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 17399968

  • 1. Gender differences in short-term effects of atorvastatin on lipid profile, fibrinolytic parameters, and endothelial function.
    Sakabe K, Fukuda N, Fukuda Y, Wakayama K, Nada T, Morishita S, Shinohara H, Tamura Y.
    Nutr Metab Cardiovasc Dis; 2008 Mar; 18(3):182-8. PubMed ID: 17399968
    [Abstract] [Full Text] [Related]

  • 2. Time course differences for statin-induced pleiotropic effects in hypercholesterolemic patients.
    Sakabe K, Fukuda N, Wakayama K, Nada T, Shinohara H, Tamura Y.
    Int J Cardiol; 2004 Mar; 94(1):111-7. PubMed ID: 14996484
    [Abstract] [Full Text] [Related]

  • 3. Short-term effects of low-dose atorvastatin on inflammatory status and lipid profiles in perimenopausal hypercholesterolemic, hypertriglyceridemic women.
    Ushiroyama T, Nosaka S, Ueki M.
    Int J Cardiol; 2006 Oct 26; 113(1):66-75. PubMed ID: 16356567
    [Abstract] [Full Text] [Related]

  • 4. Lipid-altering changes and pleiotropic effects of atorvastatin in patients with hypercholesterolemia.
    Sakabe K, Fukuda N, Wakayama K, Nada T, Shinohara H, Tamura Y.
    Am J Cardiol; 2004 Aug 15; 94(4):497-500. PubMed ID: 15325939
    [Abstract] [Full Text] [Related]

  • 5. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J, Ikeda Y, Kuribayashi T, Kajiwara K, Biro S, Yamamoto K, Ageta M, Kobori S, Saikawa T, Otonari T, Kono S.
    Clin Ther; 2008 Jun 15; 30(6):1089-101. PubMed ID: 18640465
    [Abstract] [Full Text] [Related]

  • 6. The influence of low-dose atorvastatin on lipid levels and endothelial vascular function in patients with significant coronary artery stenosis.
    Kuryata OV, Yegorova YV.
    Kardiol Pol; 2006 Jan 15; 64(1):44-8; discussion 49-50. PubMed ID: 16444629
    [Abstract] [Full Text] [Related]

  • 7. Effects of atorvastatin therapy on the low-density lipoprotein subfraction, remnant-like particles cholesterol, and oxidized low-density lipoprotein within 2 weeks in hypercholesterolemic patients.
    Sakabe K, Fukuda N, Wakayama K, Nada T, Shinohara H, Tamura Y.
    Circ J; 2003 Oct 15; 67(10):866-70. PubMed ID: 14578621
    [Abstract] [Full Text] [Related]

  • 8. Effects of atorvastatin on low-density lipoprotein cholesterol phenotype and C-reactive protein levels in patients undergoing long-term dialysis.
    Dornbrook-Lavender KA, Joy MS, Denu-Ciocca CJ, Chin H, Hogan SL, Pieper JA.
    Pharmacotherapy; 2005 Mar 15; 25(3):335-44. PubMed ID: 15843280
    [Abstract] [Full Text] [Related]

  • 9. Effect of atorvastatin therapy and conversion to tacrolimus on hypercholesterolemia and endothelial dysfunction after renal transplantation.
    Wissing KM, Unger P, Ghisdal L, Broeders N, Berkenboom G, Carpentier Y, Abramowicz D.
    Transplantation; 2006 Sep 27; 82(6):771-8. PubMed ID: 17006324
    [Abstract] [Full Text] [Related]

  • 10. The differential effect of statins on oxidative stress and endothelial function: atorvastatin versus pravastatin.
    Murrow JR, Sher S, Ali S, Uphoff I, Patel R, Porkert M, Le NA, Jones D, Quyyumi AA.
    J Clin Lipidol; 2012 Sep 27; 6(1):42-9. PubMed ID: 22264573
    [Abstract] [Full Text] [Related]

  • 11. Early effects on endothelial function of atorvastatin 40 mg twice daily and its withdrawal.
    Taneva E, Borucki K, Wiens L, Makarova R, Schmidt-Lucke C, Luley C, Westphal S.
    Am J Cardiol; 2006 Apr 01; 97(7):1002-6. PubMed ID: 16563905
    [Abstract] [Full Text] [Related]

  • 12. The effect of atorvastatin on erythrocyte membranes and serum lipids in patients with type-2 hypercholesterolemia.
    Koter M, Broncel M, Chojnowska-Jezierska J, Klikczynska K, Franiak I.
    Eur J Clin Pharmacol; 2002 Nov 01; 58(8):501-6. PubMed ID: 12451426
    [Abstract] [Full Text] [Related]

  • 13. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR, Goldstat R, Newman A, Berry K, Burger HG, Meredith I, Koch K.
    Climacteric; 2002 Dec 01; 5(4):341-50. PubMed ID: 12626213
    [Abstract] [Full Text] [Related]

  • 14. Beneficial effects of atorvastatin on sd LDL and LDL phenotype B in statin-naive patients and patients previously treated with simvastatin or pravastatin.
    Baldassarre S, Scruel O, Deckelbaum RJ, Dupont IE, Ducobu J, Carpentier YA.
    Int J Cardiol; 2005 Oct 10; 104(3):338-45. PubMed ID: 16186066
    [Abstract] [Full Text] [Related]

  • 15. Influence of withdrawal of statin treatment on proinflammatory response and fibrinolytic activity in humans: an effect independent on cholesterol elevation.
    Lai WT, Lee KT, Chu CS, Voon WC, Yen HW, Tsai LY, Sheu SH.
    Int J Cardiol; 2005 Feb 28; 98(3):459-64. PubMed ID: 15708180
    [Abstract] [Full Text] [Related]

  • 16. Lipid-independent effects of statins on endothelial function and bioavailability of nitric oxide in hypercholesterolemic patients.
    John S, Schneider MP, Delles C, Jacobi J, Schmieder RE.
    Am Heart J; 2005 Mar 28; 149(3):473. PubMed ID: 15864218
    [Abstract] [Full Text] [Related]

  • 17. Effects of Atorvastatin on LDL sub-fractions and peroxidation in type 1 diabetic patients: a randomised double-blind placebo-controlled study.
    Manuel-Y-Keenoy B, Van Campenhout C, Vertommen J, De Leeuw I.
    Diabetes Metab Res Rev; 2003 Mar 28; 19(6):478-86. PubMed ID: 14648807
    [Abstract] [Full Text] [Related]

  • 18. Effects of atorvastatin on Lp(a) and lipoprotein profiles in hemodialysis patients.
    Joy MS, Dornbrook-Lavender KA, Chin H, Hogan SL, Denu-Ciocca C.
    Ann Pharmacother; 2008 Jan 28; 42(1):9-15. PubMed ID: 18000162
    [Abstract] [Full Text] [Related]

  • 19. Effects of increasing doses of atorvastatin on the atherogenic lipid subclasses commonly associated with hypertriglyceridemia.
    Karalis DG, Ishisaka DY, Luo D, Ntanios F, Wun CC.
    Am J Cardiol; 2007 Aug 01; 100(3):445-9. PubMed ID: 17659926
    [Abstract] [Full Text] [Related]

  • 20. Effects of atorvastatin on red-blood cell Na(+)/Li(+) countertransport in hyperlipidemic patients with and without hypertension.
    Kosmidou MS, Hatzitolios AI, Adamidou A, Giannopoulos S, Raikos N, Parharidis G, Milionis HJ.
    Am J Hypertens; 2008 Mar 01; 21(3):303-9. PubMed ID: 18202666
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.